2m 2m 2m 2m 2m 2m 2m
RXSIGHT (RXST)
NASDAQ
$6.31+$0.30 (+4.93%)
Price as of Aug 03, 2026 1:54 PM EDT- $248.8MMarket Cap
- -22.95%1-Year Change
- Medical DevicesIndustry
RXSIGHT (RXST)
$6.31+$0.30 (+4.93%)
RXST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.01 | ||
Change | -$0.07 (-1.15%) | ||
Open | $6.08 | ||
High | $6.12 | ||
Low | $5.86 | ||
Previous Close | $6.08 | ||
Volume | 540,865 | ||
30-Day Average Volume | 1,191,758 | ||
1-Week Change | 15.80% | ||
1-Month Change | 24.69% | ||
1-Year Change | -22.95% | ||
3-Year Change | -81.99% | ||
5-Year Change | -62.44% | ||
Fundamentals | |||
Shares Outstanding | 41.4M | ||
Total Assets | $304.0M | ||
Market Cap | $248.8M | ||
Enterprise Value | $231.2M | ||
Period: QTR TTM FY | |||
Revenue | $30.9M | ||
Net Income | -$15.9M | ||
Free Cash Flow | -$11.7M | ||
EBIT | -$15.9M | ||
EBITDA | -$15.0M | ||
Net Working Capital | $251.8M | ||
EPS | -$0.38 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 1 | ||
P/E | -16 | ||
PEG | 0 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 9 : 1 | ||
Last Split Date | 09/21/2006 | ||
Earnings & Revenue